The present invention relates to a mutant Fibroblast Growth Factor-21 (FGF-21) peptide conjugate comprising a PEG moiety attached to a mutant FGF-21 peptide via a glycosyl linker and uses thereof. Further provided is a method for producing the mutant FGF-21 peptide conjugate and a pharmaceutical composition and container comprising said mutant FGF-21 peptide conjugate.

Edits on 2 Oct, 2023

"Add patent inventor(s)"

Golden AI

edited on 2 Oct, 2023

Edits made to:

Infobox (+2 properties)

Infobox

Patent Inventor Names

Karla K. Kopec0

Patrick Mengyuan Liu0

Edits on 22 May, 2023

"Remove website redirecting to Patent Public Search front page"

Golden AI

edited on 22 May, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=104074790

Edits on 26 Apr, 2023

"Entity importer update"

Golden AI

edited on 26 Apr, 2023

Infobox

Is a

Patent

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

104074790

Date of Patent

September 10, 2019

Patent Application Number

162256400

Date Filed

December 19, 2018

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=104074790

Patent Citations

‌

US Patent 10189883 Therapeutic uses of modified FGF-21 polypeptides

Patent Citations Received

‌

US Patent 11427623 Methods of treatment using mutant FGF-21 peptide conjugates

‌

US Patent 11510990 Conjugates of fusion proteins of GLP-1 and FGF21

‌

US Patent 11596669 Liquid formulations comprising mutant FGF-21 peptide pegylated conjugates

Patent Primary Examiner

‌

Christine J. Saoud

"update citations for inverse infoboxes"

Golden AI

edited on 26 Apr, 2023

Infobox

Patent Citations Received

‌

US Patent 11596669 Liquid formulations comprising mutant FGF-21 peptide pegylated conjugates

Edits on 5 Apr, 2023

"update citations for inverse infoboxes"

Golden AI

edited on 5 Apr, 2023

Infobox

Patent Citations Received

‌

US Patent 11427623 Methods of treatment using mutant FGF-21 peptide conjugates

Edits on 24 Mar, 2023

"update citations for inverse infoboxes"

Golden AI

edited on 24 Mar, 2023

Infobox

Patent Citations Received

‌

US Patent 11510990 Conjugates of fusion proteins of GLP-1 and FGF21

Edits on 22 Mar, 2023

"update citations for inverse infoboxes"

Golden AI

edited on 22 Mar, 2023

Infobox

Patent Citations

‌

US Patent 10189883 Therapeutic uses of modified FGF-21 polypeptides

Edits on 8 Mar, 2023

"update inverses"

Golden AI

edited on 8 Mar, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11596669 Liquid formulations comprising mutant FGF-21 peptide pegylated conjugates

Edits on 30 Nov, 2022

"update inverses"

Golden AI

edited on 30 Nov, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11510990 Conjugates of fusion proteins of GLP-1 and FGF21

Edits on 26 Sep, 2022

"update citations for inverse infoboxes"

Golden AI

edited on 26 Sep, 2022

Infobox

Patent Citations Received

‌

US Patent 11427623 Methods of treatment using mutant FGF-21 peptide conjugates

Edits on 25 Sep, 2022

"update citations for inverse infoboxes"

Golden AI

edited on 25 Sep, 2022

Infobox

Patent Citations

‌

US Patent 10189883 Therapeutic uses of modified FGF-21 polypeptides

Edits on 31 Aug, 2022

"update inverses"

Golden AI

edited on 31 Aug, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11427623 Methods of treatment using mutant FGF-21 peptide conjugates

Edits on 18 Jun, 2022

"Entity importer update"

Golden AI

edited on 18 Jun, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Website URL

https://pdfpiw.uspto.gov/.piw?Docid=10407479

Edits on 28 Jan, 2022

"Created via: Entity Importer"

Golden AI

created this topic on 28 Jan, 2022

Edits made to:

Infobox (+8 properties)

‌

US Patent 10407479 Mutant FGF-21 peptide pegylated conjugates and uses thereof

Infobox

Is a

Patent

Patent jurisdiction

United States Patent and Trademark Office

Patent number

10407479

Date of patent

September 10, 2019

Patent application number

16225640

Date Filed

December 19, 2018

Patent citations

‌

US Patent 10189883 Therapeutic uses of modified FGF-21 polypeptides

Patent primary examiner

‌

Christine J. Saoud

Find more entities like US Patent 10407479 Mutant FGF-21 peptide pegylated conjugates and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API